Page last updated: 2024-11-01

nimodipine and Tachycardia, Supraventricular

nimodipine has been researched along with Tachycardia, Supraventricular in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Tachycardia, Supraventricular: A generic expression for any tachycardia that originates above the BUNDLE OF HIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qi, XY1
Yeh, YH1
Xiao, L1
Burstein, B1
Maguy, A1
Chartier, D1
Villeneuve, LR1
Brundel, BJ1
Dobrev, D1
Nattel, S1

Other Studies

1 other study available for nimodipine and Tachycardia, Supraventricular

ArticleYear
Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current.
    Circulation research, 2008, Oct-10, Volume: 103, Issue:8

    Topics: Action Potentials; Animals; Calcineurin; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium

2008